al dementia diagnosis in a large memory clinic cohort.
Schoonenboom NS, Reesink FE, Verwey NA, Kester MI, Teunissen CE, van de Ven PM, Pijnenburg YA, Blankenstein MA, Rozemuller AJ, Scheltens P, van der Flier WM.
Neurology. 2011 Dec 14. [Epub ahead of print]
PMID: 22170879 [PubMed - as supplied by publisher]
Related citations
2.
SOD1 (Copper/Zinc Superoxide Dismutase) Deficiency Drives Amyloid β Protein Oligomerization and Memory Loss in Mouse Model of Alzheimer Disease.
Murakami K, Murata N, Noda Y, Tahara S, Kaneko T, Kinoshita N, Hatsuta H, Murayama S, Barnham KJ, Irie K, Shirasawa T, Shimizu T.
J Biol Chem. 2011 Dec 30;286(52):44557-68. Epub 2011 Nov 9.
PMID: 22072713 [PubMed - in process] Free Article
Related citations
3.
Challenges associated with curcumin therapy in Alzheimer disease.
Belkacemi A, Doggui S, Dao L, Ramassamy C.
Expert Rev Mol Med. 2011 Nov 4;13:e34.
PMID: 22051121 [PubMed - in process]
Related citations
4.
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.
Jucker M, Walker LC.
Ann Neurol. 2011 Oct;70(4):532-40. doi: 10.1002/ana.22615.
PMID: 22028219 [PubMed - in process]
Related citations
5.
Truncation of tau at E391 promotes early pathologic changes in transgenic mice.
McMillan PJ, Kraemer BC, Robinson L, Leverenz JB, Raskind M, Schellenberg G.
J Neuropathol Exp Neurol. 2011 Nov;70(11):1006-19. doi: 10.1097/NEN.0b013e31823557fb.
PMID: 22002427 [PubMed - indexed for MEDLINE]
Related citations
6.
Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.
Braak H, Thal DR, Ghebremedhin E, Del Tredici K.
J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9. doi: 10.1097/NEN.0b013e318232a379.
PMID: 22002422 [PubMed - indexed for MEDLINE]
Related citations
7.
Predicting MCI outcome with clinically available MRI and CSF biomarkers.
Heister D, Brewer JB, Magda S, Blennow K, McEvoy LK; Alzheimer's Disease Neuroimaging Initiative.
Neurology. 2011 Oct 25;77(17):1619-28. Epub 2011 Oct 12.
PMID: 21998317 [PubMed - indexed for MEDLINE]
Related citations
8.
Role of family history for Alzheimer biomarker abnormalities in the adult children study.
Xiong C, Roe CM, Buckles V, Fagan A, Holtzman D, Balota D, Duchek J, Storandt M, Mintun M, Grant E, Snyder AZ, Head D, Benzinger TL, Mettenburg J, Csernansky J, Morris JC.
Arch Neurol. 2011 Oct;68(10):1313-9.
PMID: 21987546 [PubMed - indexed for MEDLINE]
Related citations
9.
Decreases in valosin-containing protein result in increased levels of tau phosphorylated at Ser262/356.
Dolan PJ, Jin YN, Hwang W, Johnson GV.
FEBS Lett. 2011 Nov 4;585(21):3424-9. Epub 2011 Oct 5.
PMID: 21983102 [PubMed - indexed for MEDLINE]
Related citations
10.
Distinct temporal and anatomical distributions of amyloid-β and tau abnormalities following controlled cortical impact in transgenic mice.
Tran HT, Sanchez L, Esparza TJ, Brody DL.
PLoS One. 2011;6(9):e25475. Epub 2011 Sep 29.
PMID: 21980472 [PubMed - in process] Free PMC Article
Related citations
11.
Fibrillization of human tau is accelerated by exposure to lead via interaction with His-330 and His-362.
Zhu HL, Meng SR, Fan JB, Chen J, Liang Y.
PLoS One. 2011;6(9):e25020. Epub 2011 Sep 26.
PMID: 21966400 [PubMed - in process] Free PMC Article
Related citations
12.
Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.
Jung MS, Park JH, Ryu YS, Choi SH, Yoon SH, Kwen MY, Oh JY, Song WJ, Chung SH.
J Biol Chem. 2011 Nov 18;286(46):40401-12. Epub 2011 Sep 30.
PMID: 21965663 [PubMed - in process]
Related citations
13.
Alzheimer CSF biomarkers in routine clinical setting.
Tabaraud F, Leman JP, Milor AM, Roussie JM, Barrière G, Tartary M, Boutros-Toni F, Rigaud M.
Acta Neurol Scand. 2011 Sep 28. doi: 10.1111/j.1600-0404.2011.01592.x. [Epub ahead of print]
PMID: 21954973 [PubMed - as supplied by publisher]
Related citations
14.
Emerging roles of pathogens in Alzheimer disease.
Miklossy J.
Expert Rev Mol Med. 2011 Sep 20;13:e30. Review.
PMID: 21933454 [PubMed - indexed for MEDLINE]
Related citations
15.
Cerebrospinal fluid biomarkers, education, brain volume, and future cognition.
Roe CM, Fagan AM, Grant EA, Marcus DS, Benzinger TL, Mintun MA, Holtzman DM, Morris JC.
Arch Neurol. 2011 Sep;68(9):1145-51.
PMID: 21911695 [PubMed - indexed for MEDLINE]
Related citations
16.
Structural impact of proline-directed pseudophosphorylation at AT8, AT100, and PHF1 epitopes on 441-residue tau.
Bibow S, Ozenne V, Biernat J, Blackledge M, Mandelkow E, Zweckstetter M.
J Am Chem Soc. 2011 Oct 12;133(40):15842-5. Epub 2011 Sep 15.
PMID: 21910444 [PubMed - in process]
Related citations
17.
Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging.
Leyton CE, Villemagne VL, Savage S, Pike KE, Ballard KJ, Piguet O, Burrell JR, Rowe CC, Hodges JR.
Brain. 2011 Oct;134(Pt 10):3030-43. Epub 2011 Sep 9.
PMID: 21908392 [PubMed - indexed for MEDLINE]
Related citations
18.
PET imaging of brain amyloid in dementia: a review.
Quigley H, Colloby SJ, O'Brien JT.
Int J Geriatr Psychiatry. 2011 Oct;26(10):991-9. doi: 10.1002/gps.2640. Epub 2010 Dec 28. Review.
PMID: 21905095 [PubMed - indexed for MEDLINE]
Related citations
19.
[The role of CSF markers in the early diagnosis of Alzheimer's disease].
Vos SJ, Visser PJ, Verhey FR.
Tijdschr Psychiatr. 2011;53(9):647-53. Dutch.
PMID: 21898322 [PubMed - indexed for MEDLINE] Free Article
Related citations
20.
Novel demonstration of conformationally modified tau in sporadic inclusion-body myositis muscle fibers.
Nogalska A, D'Agostino C, Engel WK, Askanas V.
Neurosci Lett. 2011 Oct 10;503(3):229-33. Epub 2011 Aug 27.
PMID: 21896314 [PubMed - in process]
No comments:
Post a Comment